Sponsor:
Mayo Clinic
Code:
NCT05112614
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Electronic Health Record Review
Brief summary:
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Study ID
NCT05112614
Start date
Sep 11, 2019
Status verified date
Mar, 2026
Completion date
Oct 1, 2030
Anticipated
Primary completion date
Oct 1, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
3000 participants
Anticipated
Arms
Observational (biospecimen collection, medical record review)
Interventions
Biospecimen Collection
Electronic Health Record Review
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Principal Investigator:
Purna C. Kashyap, MBBS
Sponsor
Mayo Clinic
Last update posted
Mar 16, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-03-16.